Hi Richard,
The recent drop in JWEL's share price is largely a result of the Pfizer's vaccine news. Most every company that did well because of the pandemic (including JWEL) has suffered as a result. However, these knee-jerk reactions are unlikely to have any impacts on many of these companies.
This is especially true for JWEL. The reality is, consumers have changed their habits and there will be many permanent changes as a result of COVID-19. Think of online shopping, work from home, etc. Consumers also recognize the need to stay healthy and will continue to consume vitamins and supplements. This isn't suddenly going to stop. The vaccine is not a cure. Not only that, the world is now acutely aware that a new pandemic can arrive at anytime and it is important to ensure healthy immune systems to combat these viruses.
JWEL is ideally positioned to benefit from this and will for years to come. Perhaps growth will slow, but it continue to grow at a pretty healthy clip. IMO this pullback is healthy as it was trading at somewhat expensive valuations. It wasn't too expensive, but it did perhaps get a little ahead of itself.
Mat